WHO ICTRP trial
A trial to learn how safe baxdrostat is and how well it works in adults with…
CTIS2025-520740-16-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2025-520740-16-00 |
|---|---|
| Public title | A trial to learn how safe baxdrostat is and how well it works in adults with primary aldosteronism |
| Scientific title | A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants with Primary Aldosteronism - D6974C00001 |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | India;United Kingdom;China;Canada;Taiwan;Japan;United States;Australia;France;Germany;Spain;Italy |
| Conditions | Primary Aldosteronism defined by excess aldosterone secretion MedDRA version: 20.1Level: PTClassification code: 10036692Term: Primary hyperaldosteronism Class: 100000004860;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: Baxdrostat, Product Code:PRD10361078, Pharmaceutical Form: TABLET, Other descriptive name: , Strength: , Product Name: Baxdrostat Placebo, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A , Strength… |
| Registration date | Aug 5, 2025 |
| Target size | 180 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: